Stocks and Investing
Stocks and Investing
Tue, August 17, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 16, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Esther Hong Downgraded (APRE) to Hold on, Aug 16th, 2021
Esther Hong of Berenberg, Downgraded "Aprea Therapeutics, Inc." (APRE) to Hold on, Aug 16th, 2021.
Esther has made no other calls on APRE in the last 4 months.
There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, 1 agrees with Esther's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $100 on, Friday, August 13th, 2021
This is the rating of the analyst that currently disagrees with Esther
- Jeffrey Hung of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $60 on, Friday, August 13th, 2021
Contributing Sources